Product
MORAb-009
1 clinical trial
1 indication
Indication
MesotheliomaClinical trial
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With MesotheliomaStatus: Completed, Estimated PCD: 2011-06-30
1 clinical trial
1 indication